Conference abstract · 21 Oct 2013
Conference abstractPublished 20 Oct 2014
Anti-cancer effects of C-phycocyanin in xenograft tumor implanted mice
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Blue-green algae (cyanobacterium) are one of the most primitive life forms on earth and some of them such as Nostoc, Spirulina and Aphanizomenon species are rich in various forms of nutrients. The C-Phycocyanin (C-PC) is one such nutrient that is produced by Spirulina platensis and Limnothrix sp. 37-2-1. For the first time we have tested the anticancer properties of C-PC from the cyanobacterial isolate Limnothrix sp. 37-2-1 using cancer cells and xenograft tumor model. Our preliminary studies confirms that C-PC from Limnothrix have antiproliferative activity against LNCaP prostate cancer cells. However, as expected the required concentration of phycocyanin for anticancer activity is well above the usual doses of anticancer drugs normally used. Therefore, we speculated that C-PC could potentiate the anticancer effects of certain therapeutic agents when used in combination treatment. Initially the cytotoxic effects of C-PC and Topotecan (TPT) were confirmed using cell viability assays in A-549 lung cancer cells. Also, it was determined that C-PC treatment could completely down regulate the levels of Bcl-2, an anti-apoptotic protein, to induce apoptosis. Furthermore, our in vivo experiments confirmed the efficacy of C-PC in potentiating the anticancer effects of Taxol, Topotecan and Cisplatin in athymic nude mice that were sub-cutaneously implanted with the xenograft tumors established from A549-luc (Lung) cancer cells. During the treatment period the experimental mice had free access to C-PC dissolved in drinking water at a dose of 100 mg/Kg body weight. All the other anticancer drugs were given as intraperitoneal injections (i.p.) at a dose of 1.0 mg/kg body weight twice a week for a period of 60 days. Tumor growth was assessed once in every two weeks using caliper measurements. As a result of the treatment period, the tumor growth in the treatment groups were found to be 54%, 46% and 33% less in Taxol; TPT and Cisplatin treated groups when compared to the control group. Interestingly C-PC + Taxol combination showed 75% inhibition while C-PC + TPT showed 51% and C-PC + Cisplatin showed 40% inhibition of tumor growth. Thus, the mice treated with the C-PC + Taxol combination showed an additional 28% tumor growth inhibition when compared to group treated with Taxol alone. Results from our study confirm that C-PC from Limnothrix sp. 37-2-1 can significantly enhance the anticancer activity of Taxol against the A549-luc tumor in athymic nude mice.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 2019
Development of the humanized anti-MIC-1 monoclonal antibody repressing tumor angiogenesis in colon and prostate cancer xenograft models
Conference abstract · 2017
Development of the humanized anti-MIC-1 monoclonal antibody repressing tumor angiogenesis in colon and prostate cancer xenograft models
Commentary · 27 Nov 2024
Harnessing Tumor Angiogenesis Pathways for Anti-Cancer Drug Development
Commentary · 23 Jun 2016
Study of the Role of Anti-Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissues
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Sivanesan Dhandayuthapani”
- BylineArticles whose byline prints “Miroslav Gantar”
- BylineArticles whose byline prints “Corine Stinson”
- BylineArticles whose byline prints “Appu Rathinavelu”

